載入...
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide
Lenalidomide is clinically active in chronic lymphocytic leukemia (CLL), but its effectiveness in the context of the CLL mutational landscape is unknown. We performed targeted capture sequencing of 295 cancer genes in specimens from 102 CLL patients with treatment-naïve disease (TN patients) and 186...
Na minha lista:
| 發表在: | Blood |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909764/ https://ncbi.nlm.nih.gov/pubmed/29358183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-11-817296 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|